Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight loss benefits in clinical trials, with participants losing an average of 15% of body weight over 68 weeks. The medication works by slowing stomach emptying and signaling fullness to your brain, reducing hunger and calorie intake naturally. Understanding how dosing schedules work can help you prepare for your weight loss journey and set realistic expectations for results.

How Semaglutide Dosing Works: The Titration Schedule

Semaglutide treatment follows a 16-week titration protocol where your injection dose increases every four weeks. This gradual escalation strategy minimizes nausea and gastrointestinal side effects while allowing your metabolism to adapt at each new level. The standard protocol starts at 0.25 mg weekly and moves through 0.5 mg, 0.75 mg, and finally reaches a 1.0 mg weekly maintenance dose by week 4.

After reaching 1.0 mg weekly, most patients continue at this dose for sustained weight loss results. However, some individuals may benefit from continuing the escalation to 1.7 mg or 2.4 mg weekly doses based on their response and tolerance. Your healthcare provider adjusts your specific progression based on side effect tolerance and individual weight loss goals, meaning everyone's timeline may vary slightly.

Starting Dose and Early Weeks: What to Expect

The initial 0.25 mg dose is intentionally low to allow your gastrointestinal system time to adjust before moving to higher amounts. During weeks 1-4, most patients experience mild appetite suppression and may notice decreased interest in food or beverages they previously enjoyed. This phase establishes the foundation for your treatment and helps your prescriber assess how your body responds before increasing the dose.

Side effects during the starting phase are typically minimal compared to later doses, though some patients report mild nausea or reduced appetite from day one. Taking your injection on the same day each week and maintaining consistent meal timing helps your body establish a rhythm. Many patients find that the low starting dose is surprisingly effective for reducing cravings, even though you won't reach maximum weight loss benefit until weeks 8-12 of treatment.

Maintenance Doses and Long-Term Weight Loss Results

Most patients reach their optimal maintenance dose between 1.0 mg and 1.7 mg weekly, where sustained weight loss continues without excessive side effects. Clinical data shows that participants on the 2.4 mg dose experienced the greatest weight loss outcomes, averaging 22% body weight reduction over 68 weeks in the STEP trials. However, the 1.0 mg dose still produced meaningful results with average weight loss of 10-15%, making it effective for many individuals.

Your maintenance dose is not fixed permanently—your prescriber may adjust upward or downward based on your progress, side effect tolerance, and individual response patterns. Some patients maintain results on 1.0 mg indefinitely, while others benefit from gradual escalation to higher doses as their body adapts over months. PlexusDx provides consistent flat monthly pricing regardless of which maintenance dose your protocol requires, ensuring your cost remains predictable as your treatment evolves.

Personalized Dosing: When Genetic Testing Matters

Not all bodies respond identically to semaglutide—genetic variations in GLP-1 receptor sensitivity and other metabolic pathways influence how effectively the medication works for you. PlexusDx Precision Peptide Genetic Test examines 14 different metabolic pathways and 49 peptide-related genes, including the GLP1R rs6923761 variant that affects how your cells respond to semaglutide signals. This testing, available as a $99 add-on after your first treatment month, helps identify whether standard doses will work optimally for your genetic profile.

Patients with certain genetic variants in the MC4R gene (rs17782313) or FTO gene (rs9939609) may benefit from different dosing strategies or compound formulations to maximize results. Understanding your genetic predispositions allows your PlexusDx provider to personalize your starting dose, escalation timeline, and target maintenance level based on actual science rather than guesswork. This precision approach can accelerate your weight loss journey and reduce the likelihood of dose adjustments due to inadequate response.

Compounded Semaglutide vs. Brand-Name Wegovy: Dosing Equivalence

PlexusDx compounded semaglutide injections contain the same active pharmaceutical ingredient as brand-name Wegovy, manufactured by licensed 503A compounding pharmacies under strict quality standards. The dosing schedule, escalation protocol, and weight loss results are clinically equivalent regardless of whether you use a brand or compounded version—your body responds the same way to 0.25 mg of semaglutide whether it comes from Novo Nordisk or a licensed pharmacy. The primary difference is pricing: PlexusDx semaglutide injections start at $149 per month flat, compared to brand Wegovy costs that frequently exceed $900-$1,200 monthly without insurance.

Compounded semaglutide undergoes the same rigorous purity and potency testing as brand medications, ensuring each injection contains exactly the labeled dose. PlexusDx partners exclusively with licensed 503A compounding pharmacies—never 503B wholesalers—guaranteeing pharmacy oversight and medication quality. Your dose escalation and weight loss timeline will follow the same evidence-based 16-week titration protocol whether you choose compounded treatment, making affordability the key differentiator without sacrificing clinical effectiveness.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected subcutaneously once weekly for the first four weeks. This low dose minimizes side effects while your body adjusts to the medication. Your dose then increases gradually every four weeks through 0.5 mg, 0.75 mg, and reaches 1.0 mg maintenance by week 16.

How long does it take to reach the full weight loss dose?

The standard 16-week titration schedule allows you to reach 1.0 mg maintenance dose by the end of week 16. Maximum weight loss typically becomes apparent between weeks 12-20 as your dose reaches therapeutic levels. Some patients continue escalating to 1.7 mg or 2.4 mg if approved by their prescriber for additional benefits.

Will my price increase as my semaglutide dose goes up?

No—PlexusDx semaglutide injections maintain a flat monthly price starting at $149/month regardless of which dose level you're on. This pricing structure means your cost remains predictable whether you stay at 1.0 mg or escalate to higher maintenance doses, ensuring affordability throughout your entire treatment journey.

What are common side effects at different dose levels?

Nausea and reduced appetite are most common during the first 1-2 weeks at each new dose level, then typically subside as your body adapts. Constipation and mild stomach discomfort may occur but usually improve with hydration and fiber intake. Serious side effects are rare, but your PlexusDx prescriber monitors your response and can adjust your escalation timeline if side effects become problematic.

How does genetic testing help determine my ideal semaglutide dose?

PlexusDx Precision Peptide Genetic Test identifies your genetic variants in GLP1R, MC4R, FTO, and GIPR genes that influence semaglutide response and metabolism. This $99 add-on test reveals whether you're a likely responder to standard doses or may need personalized adjustments, helping your prescriber optimize your starting dose and escalation plan based on your unique genetic profile rather than trial-and-error.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves